Skip to main content

AMINOCAPROIC ACID

Tracking # 20-840821

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

AMINOCAPROIC ACID, AN ANTIFIBRINOLYTIC AGENT, IS A MEDICATION USED TO MANAGE AND TREAT ACUTE BLEEDING DISORDERS. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISM OF ACTION, AND CONTRAINDICATIONS FOR AMINOCAPROIC ACID AS A VALUABLE AGENT IN MANAGING HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE. THIS ACTIVITY WILL ALSO HIGHLIGHT OTHER KEY FACTORS, INCLUDING THE ADVERSE EVENT PROFILE, OFF-LABEL INDICATIONS, DOSING, AND MONITORING, PERTINENT FOR THE HEALTHCARE TEAM MEMBERS IN THE MANAGEMENT OF PATIENTS WITH ACUTE HYPERFIBRINOLYSIS-INDUCED HEMORRHAGE AND RELATED CONDITIONS.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I